1,764
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Changes in fetal presentation in the preterm period and the prediction of non-cephalic delivery

, , , , , , , , & show all
Article: 2141564 | Received 28 Jun 2022, Accepted 19 Oct 2022, Published online: 03 Nov 2022
 

Abstract

Objective

Since fetal presentation is an essential factor for planning mode of delivery, the estimation of fetal presentation at delivery is important in prenatal management. This study aimed to clarify the transition of fetal presentation during pregnancy and to propose practical strategy to predict final fetal presentation.

Methods

During the period of 2 years, fetal presentations were analyzed using ultrasonography during the prenatal visits at and after 22 weeks of gestation in a single facility. The relationship between the transition of fetal presentation and final presentation at delivery was analyzed. Further, a prediction model was developed to predict the final fetal presentation at birth.

Results

Among 1737 singleton pregnancies with full-term delivery, non-cephalic delivery occurred in 76 pregnancies (4.4%). Non-cephalic presentation in later half of the gestational period was associated with low incidence of spontaneous cephalic version. Furthermore, we found that in 46% of women with a final non-cephalic delivery, the non-cephalic presentation continued during whole of the observational period without spontaneous cephalic version. Based on the analyzed data of this cohort, we show that in a group of women with non-cephalic presentation at 35/36 weeks, the best predictability for spontaneous cephalic version depended on whether the cephalic presentation was observed at least once at and after 30 weeks of gestation.

Conclusion

Our findings suggest that information on the changes in fetal presentation during gestation contributes to the prediction of the fetal presentation at delivery and planning mode of delivery.

Ethical approval

This study was approved by the research ethics committee of the Faculty of Medicine, University of Tokyo (Approval number: 3053).

Disclosure statement

No potential conflict of interest was reported by the author(s).